We believe this is largely due to history; the codes were created when “big” specimens (L866 cases) were typically “smaller” (<10 blocks), the number of diagnostic lines less (frequently <5 lines), biomarkers (e.g. HER2 testing) did not exist, and Cancer Care Summaries (synoptic reports) did not exist. Here, ERBB2 is linked to cancer.